SCHEMBL10747528

SCHEMBL10747528

Cc1cc2nc(-n3[se]c4ccccc4c3=S)[nH]c2cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.41
▸ MAPK9 P45984 1/20 0.41
▸ MAPK10 P53779 1/20 0.41
▸ TRPV1 Q8NER1 3/20 0.40
▸ METAP2 P50579 1/20 0.39
▸ METAP1 P53582 1/20 0.39
▸ CBFB Q13951 1/20 0.39
▸ NPY5R Q15761 1/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ FGFR1 P11362 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ FABP6 P51161 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.38
▸ EGLN1 Q9GZT9 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ ATM Q13315 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ CACNA1B Q00975 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5916661 0.85 MPI (0.50) MAPK8MAPK9MAPK10METAP2NPY5R
SCHEMBL10747356 0.82 AURKA (0.44) MEN1MAPTKMT2AKDM4EALDH1A1
SCHEMBL10746112 0.72 NPC1 (0.43) METAP2MEN1MAPTKMT2AALDH1A1
SCHEMBL10501187 0.71 METAP2 (0.45) METAP2MEN1MAPTKMT2AKDM4E
SCHEMBL10747549 0.70 METAP2 (0.35) METAP2MEN1MAPTKMT2AKDM4E
SCHEMBL10747439 0.69 METAP2 (0.40) METAP2MEN1MAPTKMT2AKDM4E
SCHEMBL10501737 0.68 METAP2 (0.41) METAP2MEN1MAPTKMT2AKDM4E
SCHEMBL10501811 0.68 MPI (0.48) METAP2MEN1MAPTKMT2AKDM4E
SCHEMBL10746982 0.68 NCF1 (0.50) MEN1MAPTKMT2AKDM4EHSD17B10
SCHEMBL10502572 0.67 METAP2 (0.47) METAP2MEN1MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback